These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30452612)

  • 41. Target cardiovascular risk rather than cholesterol concentration.
    Krumholz HM
    BMJ; 2013 Nov; 347():f7110. PubMed ID: 24284344
    [No Abstract]   [Full Text] [Related]  

  • 42. Omega-3 Fatty Acids and Cardiovascular Disease Prevention.
    Tomdio A; Ritchie M; Miller AC
    Am Fam Physician; 2019 Aug; 100(4):209-210. PubMed ID: 31414778
    [No Abstract]   [Full Text] [Related]  

  • 43. Treating Dyslipidemia for the Primary and Secondary Prevention of Stroke.
    Barkas F; Milionis H
    Semin Neurol; 2017 Jun; 37(3):286-293. PubMed ID: 28759910
    [No Abstract]   [Full Text] [Related]  

  • 44. [Primary prevention and screening in adults: update 2014].
    Cornuz J; Jacot-Sadowski I; Nanchen D; Auer R; Senn N; Lazor R; Guessous I
    Rev Med Suisse; 2014 Jan; 10(414):177-8, 180-5. PubMed ID: 24624735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Evaluation of FrancoForme: A CASE-MANAGED HOME-BASED PRIMARY AND SECONDARY CARDIOVASCULAR DISEASE PREVENTION PROGRAM FOR FRENCH-SPEAKING CANADIANS.
    Prince SA; Laflamme M; Harris J; Tulloch HE; de Margerie M
    J Cardiopulm Rehabil Prev; 2017 Nov; 37(6):437-444. PubMed ID: 27496248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
    Nanna MG; Navar AM; Wang TY; Mi X; Virani SS; Louie MJ; Lee LV; Goldberg AC; Roger VL; Robinson J; Peterson ED
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory markers for risk stratification in primary prevention of cardiovascular disease: time for a 'multimarker' approach?
    Ikonomidis I; Lekakis J; Kremastinos DT
    Thromb Haemost; 2006 Mar; 95(3):397-8. PubMed ID: 16525564
    [No Abstract]   [Full Text] [Related]  

  • 48. Fasting or Nonfasting Lipid Measurements: It Depends on the Question.
    Driver SL; Martin SS; Gluckman TJ; Clary JM; Blumenthal RS; Stone NJ
    J Am Coll Cardiol; 2016 Mar; 67(10):1227-1234. PubMed ID: 26965545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspirin underuse, non-compliance or cessation: definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease.
    Biondi-Zoccai G; Wu Y; Serrano CV; Frati G; Agostoni P; Abbate A
    Int J Cardiol; 2015 Mar; 182():148-54. PubMed ID: 25577751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statin Use in Very Elderly Individuals, 1999-2012.
    Johansen ME; Green LA
    JAMA Intern Med; 2015 Oct; 175(10):1715-6. PubMed ID: 26301475
    [No Abstract]   [Full Text] [Related]  

  • 51. Cardiovascular disease screening.
    Duffy JY; Hameed AB
    Semin Perinatol; 2015 Jun; 39(4):264-7. PubMed ID: 26143091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aspirin in the Prevention of Cardiovascular Disease and Cancer.
    Ricciotti E; FitzGerald GA
    Annu Rev Med; 2021 Jan; 72():473-495. PubMed ID: 33502899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expanding the orbit of primary prevention--moving beyond JUPITER.
    Hlatky MA
    N Engl J Med; 2008 Nov; 359(21):2280-2. PubMed ID: 18997195
    [No Abstract]   [Full Text] [Related]  

  • 54. Polypill: lights and shadows.
    Teo KK; Liang Y
    Curr Hypertens Rep; 2010 Aug; 12(4):276-81. PubMed ID: 20549577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concurrent Validity of the Historical Leisure-time Physical Activity Question of the Spanish National Health Survey in Older Adults.
    Martínez-Gómez D; Guallar-Castillón P; Higueras-Fresnillo S; Rodríguez-Artalejo F
    Rev Esp Cardiol (Engl Ed); 2017 Aug; 70(8):669-670. PubMed ID: 27789171
    [No Abstract]   [Full Text] [Related]  

  • 57. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.
    Kolber MR; Korownyk C
    Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The editor's roundtable: effect of nonsteroidal anti-inflammatory drugs on blood pressure.
    Friedewald VE; Ram CV; Wesson DE; White WB; Williams GW; Roberts WC
    Am J Cardiol; 2010 Jun; 105(12):1759-67. PubMed ID: 20538127
    [No Abstract]   [Full Text] [Related]  

  • 59. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
    Yousuf O; Mohanty BD; Martin SS; Joshi PH; Blaha MJ; Nasir K; Blumenthal RS; Budoff MJ
    J Am Coll Cardiol; 2013 Jul; 62(5):397-408. PubMed ID: 23727085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guidelines for prevention of cardiovascular disease in women: a summary of recommendations.
    Mosca L
    Prev Cardiol; 2007; 10 Suppl 4():19-25. PubMed ID: 17917527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.